Combination of Panax ginseng C. A. Mey and Febuxostat Boasted Cardioprotective Effects Against Doxorubicin-Induced Acute Cardiotoxicity in Rats

• Main Authors: Hayder M. Al-Kuraishy (Author), Hany A. Al-Hussaniy (Author), Ali I. Al-Gareeb (Author), Walaa A. Negm (Author), Aya H. El-Kadem (Author), Gaber El-Saber Batiha (Author), Nermeen N. Welson (Author), Gomaa Mostafa-Hedeab (Author), Ahmed H Qasem (Author), Carlos Adam Conte-Junior (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Doxorubicin (DOX) is an anticancer agent for treating solid and soft tissue malignancies. However, the clinical use of DOX is restricted by cumulative, dose-dependent cardiotoxicity. Therefore, the present study aimed to assess the cardioprotective effects of P. ginseng C. A. Mey, febuxostat, and th...